Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

T Cell Activation and Clonal Selection

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...

T Cell Types and Functions

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...

Inhibition of Cdk Activity

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

A divergent transcriptional landscape underpins the development and functional branching of MAIT cells.

Science immunology·2019

Same author

Predictors of responses to immune checkpoint blockade in advanced melanoma.

Nature communications·2017

Same author

Granzyme M has a critical role in providing innate immune protection in ulcerative colitis.

Cell death & disease·2016

Same author

Mucosal-associated invariant T-cell activation and accumulation after in vivo infection depends on microbial riboflavin synthesis and co-stimulatory signals.

Mucosal immunology·2016

Same author

CD3bright signals on γδ T cells identify IL-17A-producing Vγ6Vδ1+ T cells.

Immunology and cell biology·2014

Same author

NK cell intrinsic regulation of MIP-1α by granzyme M.

Cell death & disease·2014

Search research articles

Related Experiment Video

Updated: Jul 14, 2026

Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells

Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells

Published on: August 1, 2025

CD1-restricted T cells and tumor immunity.

J B Swann¹, J M C Coquet, M J Smyth

¹Department of Microbiology and Immunology, University of Melbourne, 3010 Parkville, Victoria, Australia.

Current Topics in Microbiology and Immunology

|June 28, 2007

Summary

Natural killer T (NKT) cells regulate immune responses and are key in tumor immunity. Research shows NKT cells can both promote tumor rejection and suppress anti-tumor immunity, impacting immunotherapy development.

More Related Videos

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8⁺ T Cells in Mice

Published on: June 12, 2021

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8⁺ T Cell Responses

Published on: May 6, 2019

Related Experiment Videos

Last Updated: Jul 14, 2026

Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells

Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells

Published on: August 1, 2025

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8⁺ T Cells in Mice

Published on: June 12, 2021

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8⁺ T Cell Responses

Published on: May 6, 2019

Area of Science:

Immunology
Cancer Research
Immunotherapy

Background:

Natural killer T (NKT) cells are critical regulators of immune responses.
NKT cells play a significant role in tumor immunity, with research facilitated by agonist ligands and animal models.
NKT cells are involved in tumor surveillance.

Purpose of the Study:

To review the capacity of NKT cells to promote tumor rejection.
To elucidate the mechanisms by which NKT cells affect tumors.
To discuss the dual role of NKT cells in anti-tumor immunity and their therapeutic potential.

Main Methods:

Literature review of NKT cell function in tumor immunity.
Analysis of studies on NKT cell-stimulating ligands.
Examination of animal models of NKT cell and tumor interactions.

Main Results:

NKT cells can promote tumor rejection through various mechanisms.
NKT cells also possess the ability to suppress anti-tumor immune responses.
The dual role of NKT cells presents both opportunities and challenges for immunotherapy.

Conclusions:

NKT cells have a complex and multifaceted role in tumor immunity.
Understanding NKT cell mechanisms is crucial for developing effective cancer immunotherapies.
Further research into NKT cell immunotherapeutics is warranted.